hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527

被引:44
|
作者
Li, Changhui [1 ]
Zhang, Jiaqi [2 ]
Yang, Xiaohua [3 ]
Hu, Cheng [4 ]
Chu, Tianqing [1 ]
Zhong, Runbo [1 ]
Shen, Yinchen [1 ]
Hu, Fang [1 ]
Pan, Feng [1 ]
Xu, Jianlin [1 ]
Lu, Jun [1 ]
Zheng, Xiaoxuan [1 ]
Zhang, Hai [1 ]
Nie, Wei [1 ]
Han, Baohui [1 ]
Zhang, Xueyan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shanghai TCM Integrated Inst Vasc Anomalies, Shanghai TCM Integrated Hosp, Shanghai 200082, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Cent Lab, Shanghai, Peoples R China
[4] Shanghai Univ Tradit Chinese Med, Expt Ctr Sci & Technol, Shanghai 201203, Peoples R China
关键词
CIRCULAR RNA; PROLIFERATION; EPIDEMIOLOGY; EXPRESSION; MIGRATION; INVASION; NSCLC;
D O I
10.1038/s41419-021-04095-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The relationship between circular RNA (circRNA) and cancer stem cells (CSCs) is uncertain. We have investigated the combined influence of CSCs, circRNA (hsa_circ_0003222), and immune checkpoint inhibitors in NSCLC progression and therapy resistance. We constructed lung CSCs (LCSCs; PC9 and A549). The effects of hsa_circ_0003222 in vitro were determined by cell counting, colony and sphere formation, and Transwell assays. A tumor xenograft model of metastasis and orthotopic model were built for in vivo analysis. We found that hsa_circ_0003222 was highly expressed in NSCLC tissues and LCSCs. Higher levels of hsa_circ_0003222 were associated with the stage, metastasis, and survival rate of patients with NSCLC. Reduced levels of hsa_circ_0003222 decreased tumor cell proliferation, migration, invasion, stemness-like properties, and chemoresistance. The silencing of hsa_circ_0003222 was found to downregulate PHF21B expression and its downstream, beta-catenin by relieving the sponging effect of miR-527. Moreover, silencing hsa_circ_0003222 alleviated NSCLC resistance to anti-programmed cell death-ligand 1 (PD-L1)-based therapy in vivo. Our data demonstrate the significant role of hsa_circ_0003222 in NSCLC cell stemness-like properties. The manipulation of circRNAs in combination with anti-PD-L1 therapy may alleviate NSCLC stemness and progression.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p
    Xiaoping Li
    Bo Yang
    Haixia Ren
    Ting Xiao
    Liang Zhang
    Lei Li
    Mingjiang Li
    Xuhui Wang
    Honggang Zhou
    Weidong Zhang
    Cell Death & Disease, 10
  • [22] Hsa_circ_0072088 promotes non-small cell lung cancer progression through modulating miR-1270/TOP2A axis
    Sixuan Li
    Zhigang Cui
    Min Gao
    Yanan Shan
    Yihong Ren
    Yuxin Zhao
    Di Wang
    Tingyu Meng
    Hongxu Liu
    Zhihua Yin
    Cancer Cell International, 25 (1)
  • [23] Hsa_circ_0002483 inhibited the progression and enhanced the Taxol sensitivity of non-small cell lung cancer by targeting miR-182-5p
    Li, Xiaoping
    Yang, Bo
    Ren, Haixia
    Xiao, Ting
    Zhang, Liang
    Li, Lei
    Li, Mingjiang
    Wang, Xuhui
    Zhou, Honggang
    Zhang, Weidong
    CELL DEATH & DISEASE, 2019, 10 (12)
  • [24] LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP
    Lei Weng
    Kejie Qiu
    Weijing Gao
    Chunbo Shi
    Fen Shu
    BMC Pulmonary Medicine, 20
  • [25] LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP
    Weng, Lei
    Qiu, Kejie
    Gao, Weijing
    Shi, Chunbo
    Shu, Fen
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [26] The circular RNA hsa_circ_0001394 promotes hepatocellular carcinoma progression by targeting the miR-527/UBE2A axis
    Yan, Yu
    Nie, Yu
    Peng, Chun
    Xing, Fuchen
    Ji, Saiguang
    Liu, Hong
    Zhu, Chuandong
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [27] LncRNA PCAT18 Promotes Non-Small Cell Lung Cancer Progression by Sponging miR-4319
    He, Li
    Wang, Jianjun
    Zhou, Long
    Li, Xiaobing
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3761 - 3774
  • [28] Hsa_circ_0000069 Accelerates Cervical Cancer Progression by Sponging miR-1270 to Facilitate CPEB4 Expression
    Gong, Zhiyong
    Ge, Lingyan
    Ye, Saiya
    Xu, Yinyu
    BIOCHEMICAL GENETICS, 2024, 62 (03) : 1638 - 1656
  • [29] A Novel Serum Exosomes-Based Biomarker hsa_circ_0002130 Facilitates Osimertinib-Resistance in Non-Small Cell Lung Cancer by Sponging miR-498
    Ma, Jing
    Qi, Guanbin
    Li, Lei
    ONCOTARGETS AND THERAPY, 2020, 13 : 5293 - 5307
  • [30] hsa_circ_0058357 acts as a ceRNA to promote non-small cell lung cancer progression via the hsa-miR-24-3p/AVL9 axis
    Wei, Dongshan
    Sun, Lifang
    Feng, Wei
    MOLECULAR MEDICINE REPORTS, 2021, 23 (06)